The durable clearance of the T315I BCR-ABL mutated clone in chronic phase chronic myelogenous leukemia patients on omacetaxine allows tyrosine kinase inhibitor rechallenge (Q42844339)
Jump to navigation
Jump to search
scientific article published on October 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The durable clearance of the T315I BCR-ABL mutated clone in chronic phase chronic myelogenous leukemia patients on omacetaxine allows tyrosine kinase inhibitor rechallenge |
scientific article published on October 2010 |
Statements
1 reference
The durable clearance of the T315I BCR-ABL mutated clone in chronic phase chronic myelogenous leukemia patients on omacetaxine allows tyrosine kinase inhibitor rechallenge (English)
1 reference
Franck E Nicolini
1 reference
Jean-Claude Chomel
1 reference
Lydia Roy
1 reference
Laurence Legros
1 reference
Kaddour Chabane
1 reference
Sophie Ducastelle
1 reference
Emmanuelle Nicolas-Virelizier
1 reference
Mauricette Michallet
1 reference
Isabelle Tigaud
1 reference
Jean-Pierre Magaud
1 reference
Ali Turhan
1 reference
François Guilhot
1 reference
Sandrine Hayette
1 reference
1 October 2010
1 reference
1 reference
Identifiers
1 reference